首页/数据集/Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2

Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2

NCATS Open Data2022-01-07 更新2026-08-08 收录

新冠疫苗免疫应答

既往感染者疫苗效果

数据链接：

https://doi.org/10.1101/2022.01.03.22268704 数据链接链接失效反馈

官方服务：

资源简介：

Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2

应用场景：

创建时间：

2022-01-05

新冠疫苗免疫应答

单细胞免疫谱分析

mRNA vaccines, administered in two doses, have been highly effective against SARS-CoV-2 and are now being explored for broader applications. However, how human immune cells respond to these platforms,

Immunology Database and Analysis Portal2026-07-30 更新50

Table_1_Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.pdf

新冠疫苗免疫应答

体液与细胞免疫评估

IntroductionSARS-CoV-2 vaccination is the leading strategy to prevent severe courses after SARS-CoV-2 infection. In our study, we analyzed humoral and cellular immune responses in detail to three cons

NIAID Data Ecosystem30

ChAdOx1nCoV-19 vaccination

疫苗接种策略优化

新冠疫苗免疫应答

ChAd0x1 nCoV-19 (AZD 1222) is the main vaccine that is planned to roll-out in Thailand and involve vaccinating people especially in high-risk categories. This vaccine is contained in the multiple-dose

Mendeley Data2021-06-29 更新10

Modified Vaccinia Ankara Vector-Based Vaccine Protects Macaques from SARS-CoV-2 Infection, Immune Pathology and Dysfunction in the Lung

新冠疫苗免疫应答

单细胞转录组学

Study show that modified vaccinia Ankara (MVA)-based COVID-19 vaccine expressing membrane anchored pre-fusion stabilized spike (MVA/S) induces both neutralizing antibodies and CD8+ T cells in the bloo

NIAID Data Ecosystem40

Table_2_Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization.xlsx

新冠疫苗免疫应答

交叉反应抗体

Recent exposure to seasonal coronaviruses (sCoVs) may stimulate cross-reactive antibody responses against severe acute respiratory syndrome CoV 2 (SARS-CoV-2). However, previous studies have produced

NIAID Data Ecosystem30

Immune responses to inactivated and vector-based vaccines in individuals previously infected with SARS-CoV-2

资源简介：

相关数据集